Rafaela S. Ferreira, Ph.D.
Affiliations: | 2010 | Chemistry and Chemical Biology | University of California, San Francisco, San Francisco, CA |
Area:
GPCR, computational chemistryGoogle:
"Rafaela Ferreira"Mean distance: 9.91 | S | N | B | C | P |
Parents
Sign in to add mentor| Brian K. Shoichet | grad student | 2010 | UCSF | |
| (Combining virtual and high-throughput screening in the discovery of new cruzain inhibitors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Serafim MSM, Kronenberger T, Rocha REO, et al. (2024) Aminopyrimidine Derivatives as Multiflavivirus Antiviral Compounds Identified from a Consensus Virtual Screening Approach. Journal of Chemical Information and Modeling |
| Santos LH, Rocha REO, Dias DL, et al. (2023) Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays. Pharmaceuticals (Basel, Switzerland). 16 |
| Reis RCFM, Dos Santos EG, Benedetti MD, et al. (2023) Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi. European Journal of Medicinal Chemistry. 258: 115622 |
| Maltarollo VG, da Silva EB, Kronenberger T, et al. (2023) Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitors. Future Medicinal Chemistry |
| Santos VC, Leite PG, Santos LH, et al. (2023) Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles. European Journal of Medicinal Chemistry. 257: 115498 |
| Gazolla PAR, de Aguiar AR, Costa MCA, et al. (2023) Synthesis of vanillin derivatives with 1,2,3-triazole fragments and evaluation of their fungicide and fungistatic activities. Archiv Der Pharmazie. e202200653 |
| do Valle Moreira T, Martins LC, Diniz LA, et al. (2023) Screening the Pathogen Box to Discover and Characterize New Cruzain and CatL Inhibitors. Pathogens (Basel, Switzerland). 12 |
| Martins LC, de Oliveira RB, Lameira J, et al. (2023) Experimental and Computational Study of Aryl-thiosemicarbazones Inhibiting Cruzain Reveals Reversible Inhibition and a Stepwise Mechanism. Journal of Chemical Information and Modeling |
| Braga SFP, Santos VC, Vieira RP, et al. (2022) From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds. European Journal of Medicinal Chemistry. 244: 114876 |
| Qayed WS, Ferreira RS, Silva JRA. (2022) In Silico Study towards Repositioning of FDA-Approved Drug Candidates for Anticoronaviral Therapy: Molecular Docking, Molecular Dynamics and Binding Free Energy Calculations. Molecules (Basel, Switzerland). 27 |